about
Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumorTreatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group.Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours.Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.Tribute: the American Society of Pediatric Hematology/Oncology (ASPHO) 2012 distinguished career award goes to Dr. Victor Blanchette.Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5.Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.Recent advances in Wilms tumor genetics.Choroid plexus tumours.Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.Acquired von Willebrand disease in Wilms' tumor patients.Management of Wilms' tumour: current practice and future goals.Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.Rethinking pediatric assent: from requirement to ideal.Extrarenal Wilms' tumor: staging, treatment, and prognosis.Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis.Candidate genes and potential targets for therapeutics in Wilms' tumour.Diagnostic and therapeutic problems of soft tissue tumors other than rhabdomyosarcoma in infants under 1 year of age: a clinicopathological study of 34 cases treated at the Institut Gustave-Roussy.Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials.James Ewing (1866-1943): "the chief".Genetic events in the development of Wilms' tumor.Serum biological markers and paraneoplastic syndromes in Wilms tumor.The role of WT1 in Wilms tumorigenesis.Neuroblastoma stage IV-S: a heterogeneous disease.T-cell lymphoma and mature nephroblastoma after synchronous bilateral Wilms' tumor.Bilateral Wilms' tumor: long-term survival and some epidemiological features.Childhood malignant lymphoma of bone.Psychosocial services in the first 30 days after diagnosis: results of a web-based survey of Children's Oncology Group (COG) member institutions.Max Wilms (1867-1918): the man behind the eponym.Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.Pediatric oncology in Norway.Southern Alberta Children's Cancer Program.Identical APC exon 15 mutations result in a variable phenotype in familial adenomatous polyposis.
P50
Q28242483-6e52e771-4134-64d6-9177-abd5facb6c46Q33182388-fad47103-4958-5206-7c85-a5426e131b05Q33372217-5372efa5-4196-6c5a-a6cf-c25d6e09addaQ33375430-152c269c-442d-4fee-d6f7-cb7e9b29c6eeQ33400784-2626fe9e-4e29-7c74-00e4-fcc69de3f2c7Q33717311-a4a0843f-441a-19a9-300b-ce0de5cdfcbcQ34446746-54e3084d-41ea-4a3c-00f9-67287b2548f5Q34521499-1807f12e-44ce-1e23-12c6-6340434a7f99Q34981284-027c799c-4b56-d50f-0f25-ac2fccd21333Q35165770-cff1b713-4ab4-938b-ea11-fa85260ef5dbQ35225424-ebfec989-47bf-4073-8001-fc762bdd5b6dQ35618789-ea08a98c-4cf4-73e7-64ac-696542d59f4cQ36106284-2ebe3dc5-41eb-c658-1d81-77d802291989Q37074654-b94450b7-45be-6c5e-56bd-6236e18ad22eQ37155517-9fcc02bc-4d94-33c8-10f7-19688982ae1aQ37644825-8802be1a-4755-abef-ffef-b9698557944fQ37790163-ad6dbd21-4477-ddf5-f519-51fa6cc5d030Q38040205-d166f297-4d83-1da8-1746-06140bf8cdfcQ39015477-36d408e7-426b-cf70-2313-f490f889a08cQ39497022-4265cf3e-444f-09b4-86bf-510ec5160b9eQ40681250-bb7f49f7-4fa1-c272-5e88-77d948f30a08Q40851906-6065e4c7-4b42-2ad2-f823-53327446f14eQ40856549-4b2340d0-467c-cb84-6ac2-fb6ec6a76e0fQ41766721-026ac5a5-45d2-06a8-a133-4544575be8edQ43838342-4b204c0e-4aa0-5949-7e2a-bb7de227820dQ44614766-40810bdd-4174-0e73-8e49-664ece6319aaQ44925656-15a0b520-45fa-dc4c-43e2-fafb4aa0ac68Q48630144-e32df427-4547-ee9d-136b-1ee2cfe087a7Q49013713-2d079235-4669-07f6-a7af-49b537d13421Q50729780-c5e1b7ee-4350-31c3-e8c2-4b2589c059f9Q53332178-79a029f4-4572-3a4f-97e7-87d3386b3ce7Q53535215-b3bc7033-4b87-2677-31c8-f0acf84aebadQ54654862-257543aa-4ccc-7f92-abb4-20e3efe5f0e9
P50
description
kinderarts
@nl
medico
@it
physician
@en
name
Max Coppes
@nl
Max J. Coppes
@ast
Max J. Coppes
@en
Max J. Coppes
@es
type
label
Max Coppes
@nl
Max J. Coppes
@ast
Max J. Coppes
@en
Max J. Coppes
@es
altLabel
Max Coppes
@en
Max J Coppes
@en
Max J. Coppes
@nl
Max Johan Coppes
@en
prefLabel
Max Coppes
@nl
Max J. Coppes
@ast
Max J. Coppes
@en
Max J. Coppes
@es
P108
P69
P1006
P214
P227
P244
P269
P1006
P106
P108
P1153
7006046845
P21
P213
0000 0000 7735 3702
P214
P227
P244
P269
P31
P569
1957-01-01T00:00:00Z
P6815
P734
P7859
lccn-n95801248